Jazz Pharmaceuticals PLC (JAZZ)
Current ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 4,629,030 | 4,390,420 | 3,495,930 | 3,361,210 | 3,263,920 | 3,245,750 | 3,009,860 | 2,784,650 | 2,606,140 | 2,571,500 | 2,590,830 | 2,500,860 | 2,611,330 | 2,628,230 | 2,953,960 | 3,166,900 | 2,839,570 | 2,555,570 | 2,302,350 | 1,517,640 |
| Total current liabilities | US$ in thousands | 1,038,570 | 1,029,980 | 1,556,020 | 1,562,210 | 1,536,690 | 1,573,330 | 945,265 | 908,902 | 933,193 | 812,954 | 705,442 | 737,409 | 809,303 | 735,053 | 880,588 | 752,093 | 653,745 | 642,133 | 409,960 | 396,123 |
| Current ratio | 4.46 | 4.26 | 2.25 | 2.15 | 2.12 | 2.06 | 3.18 | 3.06 | 2.79 | 3.16 | 3.67 | 3.39 | 3.23 | 3.58 | 3.35 | 4.21 | 4.34 | 3.98 | 5.62 | 3.83 |
December 31, 2024 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $4,629,030K ÷ $1,038,570K
= 4.46
The current ratio of Jazz Pharmaceuticals PLC has shown fluctuations over the past few years, ranging from a low of 2.06 on September 30, 2023, to a high of 5.62 on June 30, 2020. The current ratio measures the company's ability to cover its short-term obligations with its current assets. A higher current ratio indicates a stronger liquidity position, as the company has more current assets to cover its current liabilities.
Jazz Pharmaceuticals PLC's current ratio has generally been above 2, which is generally considered acceptable in most industries. However, the ratio experienced a significant drop to 2.06 on September 30, 2023, which might indicate potential challenges in meeting short-term obligations at that time. The company managed to improve the ratio in the following periods, reaching 4.46 by December 31, 2024, indicating a more favorable liquidity position.
It is essential for investors and stakeholders to monitor the company's current ratio over time to assess its ability to manage short-term obligations and maintain financial stability. A consistent and healthy current ratio is crucial for the company's operational efficiency and financial health.
Peer comparison
Dec 31, 2024